EC Number | Cloned (Comment) | Organism |
---|---|---|
1.14.13.39 | expression of His-tagged NOS oxygenase domain lacking the N-terminal 114 residues in Escherichia coli | Mus musculus |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.14.13.39 | orthorhombic crystals from NOS oxygenase domain lacking the N-terminal 114 residues, preparation in presence of imidazole, structure analysis via x-ray diffraction, also with bound inhibitor N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)-piperazine-2-acetamide | Mus musculus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.14.13.39 | additional information | monomers encoding NOS oxygenase domain lacking the N-terminal 114 residues, His-tagged, expression in Escherichia coli | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.13.39 | N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)-piperazine-2-acetamide | inhibition of dimer formation in vivo and in vitro, efficiency is dependent on enzyme source | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.13.39 | 2 L-arginine + 3 NADPH + 4 O2 + 3 H+ | Homo sapiens | - |
2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O | - |
? | |
1.14.13.39 | 2 L-arginine + 3 NADPH + 4 O2 + 3 H+ | Mus musculus | - |
2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.13.39 | Homo sapiens | - |
inducible | - |
1.14.13.39 | Mus musculus | P29477 | cytokine-inducible in macrophage | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.13.39 | glioblastoma cell | cell line A-172, american type | Homo sapiens | - |
1.14.13.39 | macrophage | - |
Homo sapiens | - |
1.14.13.39 | macrophage | RAW 264.7 cells | Mus musculus | - |
1.14.13.39 | macrophage | cytokine-activated | Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.13.39 | 2 L-arginine + 3 NADPH + 4 O2 + 3 H+ | - |
Homo sapiens | 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O | - |
? | |
1.14.13.39 | 2 L-arginine + 3 NADPH + 4 O2 + 3 H+ | - |
Mus musculus | 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O | - |
? | |
1.14.13.39 | 2 L-arginine + 3 NADPH + 4 O2 + 3 H+ | dimeric structure is required for enzyme activity | Mus musculus | 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O | - |
? | |
1.14.13.39 | oxidized cytochrome c + NADPH + O2 | - |
Homo sapiens | reduced cytochrome c + NADP+ + H2O | - |
? | |
1.14.13.39 | oxidized cytochrome c + NADPH + O2 | - |
Mus musculus | reduced cytochrome c + NADP+ + H2O | - |
? |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.13.39 | NADPH | - |
Homo sapiens | |
1.14.13.39 | NADPH | - |
Mus musculus |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.14.13.39 | 0.0000022 | - |
N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)-piperazine-2-acetamide | - |
Mus musculus |